Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments
The DOI matches its Crossref record; 125 of the 125 references it cites were found in a registry or an index.
Abstract
Glutamate and gamma-amino butyric acid (GABA) systems are emerging as targets for development of medications for mood disorders. There is increasing preclinical and clinical evidence that antidepressant drugs directly or indirectly reduce N-methyl-D-aspartate glutamate receptor function. Drugs that reduce glutamatergic activity or glutamate receptor-related signal transduction may also have antimanic effects. Recent studies employing magnetic resonance spectroscopy also suggest that unipolar, but not bipolar, depression is associated with reductions in cortical GABA levels. Antidepressant and mood-stabilizing treatments also appear to raise cortical GABA levels and to ameliorate GABA deficits in patients with mood disorders. The preponderance of available evidence suggests that glutamatergic and GABAergic modulation may be an important property of available antidepressant and mood-stabilizing agents. Future research will be needed to develop and evaluate new agents with specific glutamate and GABA receptor targets in the treatment of mood disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mood disorders have been associated with abnormalities of serotonergic, dopaminergic, noradrenergic, cholinergic, glutamatergic, GABAergic, glucocorticoid, and peptidergic function (Drevets et al, 2007;Nestler and Carlezon, 2006;Krystal et al, 2002;Gold et al, 2002).”
From Neurocircuitry of Mood Disorders (2010) · cites this paper as Krystal et al, 2002
In the citing paper
“antidepressant and mood-stabilizing drugs which have diverse primary pharmacological actions generally reduce NMDA receptor sensitivity and/or transmission, and many of these agents increase GABA levels or transmission (Krystal et al. 2002; Paul and Skolnick 2003).”
From Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression (2008) · cites this paper as Krystal et al. 2002
In the citing paper
“Ketamine (an NMDA receptor antagonist) affects fast excitatory glutamate transmission, increases release of brain-derived neurotrophic factor, and stimulates synaptogenesis (7).”
Citations
Cites
Antidepressant effects of ketamine in depressed patients
Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856
Self-citationKrystal, J. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030035004 · Cited by 3,330
Self-citationArzneimittelforschung: Eine Zukunftsoption für Ärzte?
Bethke, T. D. (2012) · Der Pneumologe · doi:10.1007/s10405-012-0601-3 · Cited by 3,261
Subgenual prefrontal cortex abnormalities in mood disorders
Drevets, W. C., Price, J. L., Simpson, J. R., Todd, R. D., Reich, T., Vannier, M., & Raichle, M. E. (1997) · Nature · doi:10.1038/386824a0 · Cited by 2,693
Mayberg, H. S., Liotti, M., Brannan, S. K., McGinnis, S., Mahurin, R. K., Jerabek, P. A., Silva, J. A., Tekell, J. L., Martin, C. C., Lancaster, J. L., et al. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.5.675 · Cited by 2,416
Glucocorticoids and Hippocampal Atrophy in Neuropsychiatric Disorders
Sapolsky, R. M. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.10.925 · Cited by 2,016
Hippocampal atrophy in recurrent major depression
Sheline, Y. I., Wang, P. W., Gado, M. H., Csernansky, J. G., & Vannier, M. W. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.3908 · Cited by 1,932
Moghaddam, B., Adams, B., Verma, A., & Daly, D. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02921.1997 · Cited by 1,793
Hippocampal Volume Reduction in Major Depression
Bremner, J. D., Narayan, M., Anderson, E. R., Staib, L. H., Miller, H. L., & Charney, D. S. (2000) · American Journal of Psychiatry · doi:10.1176/ajp.157.1.115 · Cited by 1,670
Self-citationGlial reduction in the subgenual prefrontal cortex in mood disorders
Öngür, D., Drevets, W. C., & Price, J. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13290 · Cited by 1,525
Rajkowska, G., Miguel-Hidalgo, J. J., Wei, J., Dilley, G., Pittman, S. D., Meltzer, H. Y., Overholser, J. C., Roth, B. L., & Stockmeier, C. A. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00041-4 · Cited by 1,477
A functional anatomical study of unipolar depression
Drevets, W., Videen, T., Price, J., Preskorn, S., Carmichael, S., & Raichle, M. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-09-03628.1992 · Cited by 1,266
Magistretti, P. J., Pellerin, L., Rothman, D. L., & Shulman, R. G. (1999) · Science · doi:10.1126/science.283.5401.496 · Cited by 1,170
Calabrese, J. R., Bowden, C. L., Sachs, G. S., Ascher, J. A., Monaghan, E., Rudd, G. D., & The Lamictal 602 Study Group (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0203 · Cited by 1,054
Reversal of Phencyclidine Effects by a Group II Metabotropic Glutamate Receptor Agonist in Rats
Moghaddam, B., & Adams, B. W. (1998) · Science · doi:10.1126/science.281.5381.1349 · Cited by 1,006
Study of a New Schizophrenomimetic Drug—Sernyl
LUBY, E. D. (1959) · Archives of Neurology And Psychiatry · doi:10.1001/archneurpsyc.1959.02340150095011 · Cited by 921
Extracellular hippocampal glutamate and spontaneous seizure in the conscious human brain
During, M. J., & Spencer, D. D. (1993) · The Lancet · doi:10.1016/0140-6736(93)90754-5 · Cited by 902
(2000) · PubMed · Cited by 685
Neural plasticity to stress and antidepressant treatment
Duman, R. S., Malberg, J., & Thome, J. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00177-8 · Cited by 645
Sanacora, G., Mason, G. F., Rothman, D. L., Behar, K. L., Hyder, F., Petroff, O. A. C., Berman, R. M., Charney, D. S., & Krystal, J. H. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.11.1043 · Cited by 627
Self-citationAuer, D. P., Pütz, B., Kraft, E., Lipinski, B., Schill, J., & Holsboer, F. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00159-6 · Cited by 564
Prefrontal cortical-amygdalar metabolism in major depression.
DREVETS, W. C. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb09292.x · Cited by 557
Jakab, R. L., & Goldman-Rakic, P. S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.2.735 · Cited by 536
Serotonin model of schizophrenia: emerging role of glutamate mechanisms
Aghajanian, G. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00046-6 · Cited by 529
Localized 1H NMR measurements of gamma-aminobutyric acid in human brain in vivo.
Rothman, D. L., Petroff, O. A., Behar, K. L., & Mattson, R. H. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.12.5662 · Cited by 509
Prefrontal cortex regulates inhibition and excitation in distributed neural networks
Knight, R. T., Richard Staines, W., Swick, D., & Chao, L. L. (1999) · Acta Psychologica · doi:10.1016/s0001-6918(99)00004-9 · Cited by 498
Stahl, S. M. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n0103 · Cited by 489
The role of glutamate in epilepsy and other CNS disorders.
Meldrum, B. S. (1994) · PubMed · Cited by 479
Long Term Lithium Treatment Suppresses p53 and Bax Expression but Increases Bcl-2 Expression
Chen, R.-W., & Chuang, D.-M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.10.6039 · Cited by 469
NMDA-dependent modulation of CA1 local circuit inhibition
Grunze, H., Rainnie, D., Hasselmo, M., Barkai, E., Hearn, E., McCarley, R., & Greene, R. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-06-02034.1996 · Cited by 467
Determination of the rate of the glutamate/glutamine cycle in the human brain by in vivo 13 C NMR
Shen, J., Petersen, K. F., Behar, K. L., Brown, P., Nixon, T. W., Mason, G. F., Petroff, O. A. C., Shulman, G. I., Shulman, R. G., & Rothman, D. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.14.8235 · Cited by 462
Self-citationFitzgerald, L., Ortiz, J., Hamedani, A., & Nestler, E. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-01-00274.1996 · Cited by 450
Ketamine activates psychosis and alters limbic blood flow in schizophrenia
Lahti, A. C., Holcomb, H. H., Medoff, D. R., & Tamminga, C. A. (1995) · NeuroReport · doi:10.1097/00001756-199504190-00011 · Cited by 434
Nonaka, S., Hough, C. J., & Chuang, D.-M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2642 · Cited by 427
Anand, A., Charney, D. S., Oren, D. A., Berman, R. M., Hu, X. S., Cappiello, A., & Krystal, J. H. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.3.270 · Cited by 426
Self-citationSchell, M. J., Brady Jr., R. O., Molliver, M. E., & Snyder, S. H. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-05-01604.1997 · Cited by 415
Vollenweider, F. X., Leenders, K. L., Øye, I., Hell, D., & Angst, J. (1997) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(96)00042-9 · Cited by 413
(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.6.805 · Cited by 392
Rutherford, L. C., DeWan, A., Lauer, H. M., & Turrigiano, G. G. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-12-04527.1997 · Cited by 381
Hippocampal volume in geriatric depression
Steffens, D. C., Byrum, C. E., McQuoid, D. R., Greenberg, D. L., Payne, M. E., Blitchington, T. F., MacFall, J. R., & Krishnan, K. R. R. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00829-5 · Cited by 379
GABA and mood disorders: a brief review and hypothesis
Petty, F. (1995) · Journal of Affective Disorders · doi:10.1016/0165-0327(95)00025-i · Cited by 377
Progesterone metabolite allopregnanolone in women with premenstrual syndrome
RAPKIN, A., MORGAN, M., GOLDMAN, L., BRANN, D., SIMONE, D., & MAHESH, V (1997) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(97)00417-1 · Cited by 376
Skolnick, P., Layer, R., Popik, P., Nowak, G., Paul, I., & Trullas, R. (1996) · Pharmacopsychiatry · doi:10.1055/s-2007-979537 · Cited by 344
Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents — preclinical studies
Danysz, W., Parsons, C. G., Kornhuber, J., Schmidt, W. J., & Quack, G. (1997) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(96)00037-1 · Cited by 322
Mason, G. F., Gruetter, R., Rothman, D. L., Behar, K. L., Shulman, R. G., & Novotny, E. J. (1995) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1995.2 · Cited by 309
Self-citationRostral and Orbital Prefrontal Cortex Dysfunction in the Manic State of Bipolar Disorder
Blumberg, H. P., Stern, E., Ricketts, S., Martinez, D., de Asis, J., White, T., Epstein, J., Isenberg, N., McBride, P. A., Kemperman, I., et al. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.12.1986 · Cited by 289
Self-citationThe effect of gabapentin on brain gamma‐aminobutyric acid in patients with epilepsy
Petroff, O. A. C., Rothman, D. L., Behar, K. L., Lamoureux, D., & Mattson, R. H. (1996) · Annals of Neurology · doi:10.1002/ana.410390114 · Cited by 285
Marek, G. J., Wright, R. A., Schoepp, D. D., Monn, J. A., & Aghajanian, G. K. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35262-0 · Cited by 280
Self-citationIncreased anterior cingulate and caudate activity in bipolar mania
Blumberg, H. P., Stern, E., Martinez, D., Ricketts, S., de Asis, J., White, T., Epstein, J., McBride, P. A., Eidelberg, D., Kocsis, J. H., et al. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00962-8 · Cited by 277
Self-citationNowak, G., Ordway, G. A., & Paul, I. A. (1995) · Brain Research · doi:10.1016/0006-8993(95)00057-w · Cited by 262
Goddard, A. W., Mason, G. F., Almai, A., Rothman, D. L., Behar, K. L., Petroff, O. A. C., Charney, D. S., & Krystal, J. H. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.6.556 · Cited by 255
Self-citationManji, H. K., & Lenox, R. H. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00235-8 · Cited by 241
Adaptation of the N-methyl-D-aspartate receptor complex following chronic antidepressant treatments.
Paul, I. A., Nowak, G., Layer, R. T., Popik, P., & Skolnick, P. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38715-x · Cited by 241
Mechanism of Disinhibition After Brain Lesions
STARKSTEIN, S. E., & ROBINSON, R. G. (1997) · The Journal of Nervous & Mental Disease · doi:10.1097/00005053-199702000-00007 · Cited by 225
Sackeïm, H. A., Decina, P., Prohovnik, I., Malitz, S., & Resor, S. R. (1983) · PubMed · Cited by 211
MOLECULAR BIOLOGY OF MAMMALIAN AMINO ACID TRANSPORTERS
Malandro, M. S., & Kilberg, M. S. (1996) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.65.070196.001513 · Cited by 210
The Relationship Between Panic Disorder and Major Depression: A New Family Study
Weissman, M. M. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820220017003 · Cited by 196
Tricyclic antidepressants block N‐methyl‐D‐aspartate receptors: similarities to the action of zinc
Reynolds, I. J., & Miller, R. J. (1988) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1988.tb16552.x · Cited by 191
Allopregnanolone concentrations and premenstrual syndrome
Monteleone, P., Luisi, S., Tonetti, A., Bernardi, F., Genazzani, A., Luisi, M., Petraglia, F., & Genazzani, A. (2000) · European Journal of Endocrinology · doi:10.1530/eje.0.1420269 · Cited by 186
Schmidt, P. J. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.79.5.1256 · Cited by 184
Interactive effects of subanesthetic ketamine and subhypnotic lorazepam in humans
Krystal, J. H., Karper, L. P., Bennett, A., D'Souza, D. C., Abi-Dargham, A., Morrissey, K., Abi-Saab, D., Bremner, J. D., Bowers Jr., M. B., Suckow, R. F., et al. (1998) · Psychopharmacology · doi:10.1007/s002130050503 · Cited by 184
Self-citationRichards, F. (1965) · The Lancet · doi:10.1016/s0140-6736(65)90780-4 · Cited by 176
Manji, H. K., Bebchuk, J. M., Moore, G. J., Glitz, D. A., Hasanat, K., & Chen, G. (1999) · PubMed · Cited by 170
Cunningham, M. O., & Jones, R. S. G. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00051-4 · Cited by 161
Low brain GABA level is associated with poor seizure control
Petroff, O. A. C., Rothman, D. L., Behar, K. L., & Mattson, R. H. (1996) · Annals of Neurology · doi:10.1002/ana.410400613 · Cited by 160
Scruggs, J. L., Patel, S., Bubser, M., & Deutch, A. Y. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-23-08846.2000 · Cited by 154
Dixon, J. F., & Hokin, L. E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8363 · Cited by 149
Henderson, G., Johnson, J. W., & Ascher, P. (1990) · The Journal of Physiology · doi:10.1113/jphysiol.1990.sp018288 · Cited by 141
Vaidya, V. A., Terwilliger, R. M. Z., & Duman, R. S. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00006-3 · Cited by 140
Impairment of GABAergic Transmission in Depression: New Insights from Neuroimaging Studies
Sanacora, G., Mason, G. F., & Krystal, J. H. (2000) · Critical Reviews™ in Neurobiology · doi:10.1615/critrevneurobiol.v14.i1.20 · Cited by 132
Self-citationDepression Among Alcoholics: Relationship to Clinical and Cerebrospinal Fluid Variables
Roy, A. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810290040007 · Cited by 132
Waldmeier, P. C., Baumann, P. A., Wicki, P., Feldtrauer, J.-J., Stierlin, C., & Schmutz, M. (1995) · Neurology · doi:10.1212/wnl.45.10.1907 · Cited by 128
CYLOSERINE AS AN ANTIDEPRESSANT AGENT
CRANE, G. E. (1959) · American Journal of Psychiatry · doi:10.1176/ajp.115.11.1025 · Cited by 127
Marek, G. J., McDougle, C. J., Price, L. H., & Seiden, L. S. (1992) · Psychopharmacology · doi:10.1007/bf02245475 · Cited by 122
Self-citationGörtelmeyer, R., & Erbler, H. C. (1992) · PubMed · Cited by 121
Topiramate increases brain GABA, homocarnosine, and pyrrolidinone in patients with epilepsy
Petroff, O. A. C., Hyder, F., Mattson, R. H., & Rothman, D. L. (1999) · Neurology · doi:10.1212/wnl.52.3.473 · Cited by 119
GABAergic modulation of learned helplessness
Petty, F., & Sherman, A. D. (1981) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(81)90210-0 · Cited by 118
Systemic PCP treatment elevates brain extracellular 5-HT: a microdialysis study in awake rats
Martin, P., Carlsson, M. L., & Hjorth, S. (1998) · NeuroReport · doi:10.1097/00001756-199809140-00012 · Cited by 118
Childhood adversity and vulnerability to mood and anxiety disorders
Young, E. A., Abelson, J. L., Curtis, G. C., & Nesse, R. M. (1997) · Depression and Anxiety · doi:10.1002/(sici)1520-6394(1997)5:2<66::aid-da2>3.0.co;2-3 · Cited by 115
Therapeutic brain concentration of the NMDA receptor antagonist amantadine
Kornhuber, J., Quack, G., Danysz, W., Jellinger, K. A., Danielczyk, W., Gsell, W., & Riederer, P. F. (1995) · Neuropharmacology · doi:10.1016/0028-3908(95)00056-c · Cited by 115
Parsons, C. G., Panchenko, V. A., Pinchenko, V. O., Tsyndrenko, A. Y., & Krishtal, O. A. (1996) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1996.tb01228.x · Cited by 114
Actions of ?-cycloserine at the ? glycine receptor site in vivo
Emmett, M. R. (1991) · Neuropharmacology · doi:10.1016/0028-3908(91)90161-4 · Cited by 108
Monihan, J. B., Corpus, V. M., Hood, W. F., Thomas, J. W., & Compton, R. P. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb07344.x · Cited by 105
Antipsychotics in the treatment of mood disorders and risk of tardive dyskinesia.
Keck, P. E., McElroy, S. L., Strakowski, S. M., & Soutullo, C. A. (2000) · PubMed · Cited by 103
The gabaergic hypothesis of depression
Lloyd, K. G., Živković, B., Scatton, B., Morselli, P. L., & Bartholimi, G. (1989) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(89)90123-1 · Cited by 103
Guille, C., Sachs, G. S., & Ghaemi, S. N. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n0907 · Cited by 101
Different mechanisms of protection against apoptosis by valproate and Li+
Mora, A., González‐Polo, R. A., Fuentes, J. M., Soler, G., & Centeno, F. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00919.x · Cited by 101
Adjunctive treatment of manic agitation with lorazepam versus haloperidol: a double-blind study.
Lenox, R. H., NEWHOUSE, P. A., Creelman, W., & Whitaker, T. M. (1992) · PubMed · Cited by 99
Possible Use of Amantadine in Depression
Huber, T., Dietrich, D., & Emrich, H. (1999) · Pharmacopsychiatry · doi:10.1055/s-2007-979191 · Cited by 97
Allopregnanolone in Women with Premenstrual Syndrome
Bičíková, M., Dibbelt, L., Hiill, M., Hampl, R., & Stárka, L. (1998) · Hormone and Metabolic Research · doi:10.1055/s-2007-978871 · Cited by 96
Human brain GABA levels rise rapidly after initiation of vigabatrin therapy
Petroff, O. A. C., Rothman, D. L., Behar, K. L., Collins, T., & Mattson, R. H. (1996) · Neurology · doi:10.1212/wnl.47.6.1567 · Cited by 94
Ikonomov, O. C., & Manji, H. K. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.10.1506 · Cited by 94
Measuring human brain GABA in vivo
Petroff, O. A. C., & Rothman, D. L. (1998) · Molecular Neurobiology · doi:10.1007/bf02740605 · Cited by 92
Bode, L., Dietrich, D. E., Stoyloff, R., Emrich, H. M., & Ludwig, H. (1997) · The Lancet · doi:10.1016/s0140-6736(05)60979-8 · Cited by 85
AMANTADINE DOSAGE IN TREATMENT OF PARKINSON'S DISEASE
Parkes, J. D., Zilkha, K. J., Marsden, P. D., Baxter, R. C., & Knill-Jones, R. P. (1970) · The Lancet · doi:10.1016/s0140-6736(70)91211-0 · Cited by 77
Waldmeier, P. C., Martin, P., St�cklin, K., Portet, C., & Schmutz, M. (1996) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00178716 · Cited by 74
Double-Blind Comparison of the Effects of Clonazepam and Lorazepam in Acute Mania
Bradwejn, J., Shriqui, C. L., Koszycki, D., & Meterissian, G. B. (1990) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199010060-00004 · Cited by 72
FOLEY, D. L., NEALE, M. C., & KENDLER, K. S. (1998) · Psychological Medicine · doi:10.1017/s0033291798006977 · Cited by 71
Calabresi, P., Centonze, D., Marfia, G. A., Pisani, A., & Bernardi, G. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702361 · Cited by 71
Lingamaneni, R., & Hemmings Jr, H. C. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00810-1 · Cited by 68
Priestley, T., & Kemp, J. A. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09868-2 · Cited by 67
Pathophysiology of Secondary Depressions in the Elderly
Robinson, R. G., Chemerinski, E., & Jorge, R. E. (1999) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/089198879901200306 · Cited by 65
Vale, S., Espejel, M. A., & Dominguez, J. C. (1971) · The Lancet · doi:10.1016/s0140-6736(71)90153-x · Cited by 64
Krupitsky, E. M., Burakov, A. M., Romanova, T. N., Grinenko, N. I., Grinenko, A. Y., Fletcher, J., Petrakis, I. L., & Krystal, J. H. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00346-3 · Cited by 61
Biology of schizophrenia and affective disease
Alarcón, R. D. (1997) · Depression and Anxiety · doi:10.1002/(sici)1520-6394(1997)5:2<112::aid-da9>3.0.co;2-h · Cited by 59
The psychotropic effects of cycloserine: A new use for an antibiotic
Crane, G. E. (1961) · Comprehensive Psychiatry · doi:10.1016/s0010-440x(61)80007-2 · Cited by 55
Papp, M., & Moryl, E. (1993) · PubMed · Cited by 51
Ambrozi, L., & Danielczyk, W. (1988) · Pharmacopsychiatry · doi:10.1055/s-2007-1014666 · Cited by 49
Zubenko, G. S. (1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.10.1306 · Cited by 48
Swim Stress Increases the Potency of Glycine at the N‐Methyl‐d‐Aspartate Receptor Complex
Nowak, G., Redmond, A., McNamara, M., & Paul, I. A. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64020925.x · Cited by 43
Wędzony, K., Maćkowiak, M., Czyrak, A., Fijał, K., & Michalska, B. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00159-5 · Cited by 42
Clonidine in the treatment of mania and mixed bipolar disorder
Zubenko, G. S., Cohen, B. M., Lipinski, J. F., & Jonas, J. M. (1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.12.1617 · Cited by 42
The effect of repeated electroconvulsive shock on GABA synthesis and release in regions of rat brain
Green, A. R., & Vincent, N. D. (1987) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1987.tb11290.x · Cited by 40
Lejeune, F., Gobert, A., Rivet, J., & Mark, J. M. (1994) · Brain Research · doi:10.1016/0006-8993(94)91490-7 · Cited by 34
Bovill, J. G., CLARKE, R. S. J., DUNDEE, J. W., Pandit, S. K., & MOORE, J. (1971) · British Journal of Anaesthesia · doi:10.1093/bja/43.6.600 · Cited by 33
Pallotta, M., Segieth, J., & Whitton, P. S. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01333-4 · Cited by 31
Comparison of clonidine and lithium in the treatment of mania
Giannini, A. J., Pascarzi, G. A., Loiselle, R. H., Price, W. A., & Giannini, M. C. (1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.12.1608 · Cited by 23
Inhibition of N-methyl-l-aspartate activated ion current by desmethylimipramine
White, G., Lovinger, D. M., Peoples, R. W., & Weight, F. F. (1990) · Brain Research · doi:10.1016/0006-8993(90)90381-k · Cited by 21
Depression, Borna disease, and amantadine
Lieb, K., Hufert, F. T., Bechter, K., Bauer, J., & Kornhuber, J. (1997) · The Lancet · doi:10.1016/s0140-6736(05)62741-9 · Cited by 19
Wędzony, K., Klimek, V., & Nowak, G. (1995) · PubMed · Cited by 14
304. Cortical GABA reduced in unipolar but not bipolar depression
Mason, G. F., Sanacora, G., Anand, A., Epperson, C. N., Goddard, A. W., Rothman, D. L., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00568-0 · Cited by 11
Self-citationAmantadine-induced aggressiveness.
Rizzo, M., & Morselli, P. L. (1972) · BMJ · doi:10.1136/bmj.3.5817.50 · Cited by 6
1. ECT Effects on Cortical GABA Levels as Determined by 1H-MRS
Sanacora, G., Mason, G. F., Rothman, D. L., Berman, R., Charney, D. S., Ciarcia, J. J., & Krystal, J. H. (1999) · Journal of Ect · doi:10.1097/00124509-199903000-00009 · Cited by 5
Self-citationDg, G.-S. (1984) · PubMed · Cited by 4
Blockade of ketamine-induced psychosis: A human model for a new spectrum of antipsychotic activity?
Lahti, A. C., Weiler, M. A., Parwani, A., Holcomb, H. H., & Tamminga, C. A. (2000) · Schizophrenia Research · doi:10.1016/s0920-9964(00)90893-4 · Cited by 1
Research works printed but not linked: 9
- Delgado PL . Depression: the case for a monoamine deficiency J Clin Psychiatry 2000 61 (Suppl 6): 7–11
- Cappiello A, Charney DS, Berman R et al. NMDA receptor function in major depression Biol Psychiatry 1997 41: 45S
- Mason GF, Haga K, Appel M et al. Measuring cortical GABA levels and neurotransmitter turnover with 1H-MRS and 13C-MRS Biol Psychiatry 2001 49: 148S
- Krystal JH, Petrakis IL, D'Souza DC, Trevisan L, Krasnicki S, Charney DS . Interactive effects of high dose intravenous glycine and oral D-cycloserine in healthy human subjects Biol Psychiatry 1997 41 (Suppl): 23S
- Blumberg HP, Leung HC, Wexler B et al. Ventral prefrontal dysfunction in bipolar disorder: an fMRI study Biol Psychiatry 2001 49: 26S
- Krystal JH, Belger A, Kirino E, Gore J, McCarthy G . Ketamine effects on the cortical processing of novelty in humans assessed with fMRI Soc Neurosci Abstr 1998 24: 104.7
- Newcomer JW, Farber NB, Selke G, Melson AK, Jevtovic-Todorovic V, Olney JW . Guanabenz effects on NMDA antagonist-induced mental symptoms in human Soc Neurosci Abstr 1998 24: 211.2
- Lahti AC, Weiler MA, Parwani A et al. Blockade of ketamine-induced psychosis with olanzepine Schizophr Res 1999 36: 310
- Epperson CN, Mason G, Rothman DR, Sanacora G, Krystal JH . GABA dysregulation in premenstrual dysphoric disorder Soc Neurosci Abstr 1999 25: 2227
Cited by
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
The Wellcome Trust Case Control Consortium, Management Committee, Burton, P. R., Clayton, D. G., Cardon, L. R., Craddock, N., Deloukas, P., Duncanson, A., Kwiatkowski, D. P., McCarthy, M. I., et al. (2007) · Nature · doi:10.1038/nature05911 · Cited by 9,442
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.856 · Cited by 3,766
Self-citationDrevets, W. C., Price, J. L., & Furey, M. L. (2008) · Brain Structure and Function · doi:10.1007/s00429-008-0189-x · Cited by 2,241
“Moreover, antidepressant and mood-stabilizing drugs which have diverse primary pharmacological actions generally reduce NMDA receptor sensitivity and/or transmission, and many of these agents increase GABA levels or transmission (Krystal et al. 2002; Paul and Skolnick 2003).”
BackgroundCryan, J. F., Mombereau, C., & Vassout, A. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.009 · Cited by 1,674
Metadata
- Authors
- Krystal, J. H., Sanacora, G., Blumberg, H., Anand, A., Charney, D. S., Marek, G., Epperson, C. N., Goddard, A., & Mason, G. F.
- Affiliations
- Yale University (US)
- Corresponding author
- Krystal, J H
- Venue
- Molecular Psychiatry
- Published
- 2002-01-01
- Volume
- 7
- Issue
- S1
- Pages
- S71-S80
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- OpenAlex
- W2023866167
- Cited by
- 553
- References
- 124
- Citations by year
- 2026: 8 · 2025: 14 · 2024: 14 · 2023: 17 · 2022: 17 · 2021: 49 · 2020: 21 · 2019: 16 · 2018: 20 · 2017: 17 · 2016: 29 · 2015: 19 · 2014: 25 · 2013: 31 · 2012: 28
- FWCI
- 2.41
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Molecular Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Mental Health (K23MH001830)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Keywords
- glutamate, GABA, antidepressants, mood stabilizers, mood disorders, depression, mania, NMDA receptor, glutamatergic signaling, bipolar disorder, major depressive disorder, therapeutic target
- MeSH terms
- Antidepressive Agents, gamma-Aminobutyric Acid, Humans, Models, Neurological, Synaptic Transmission, Glutamic Acid, Mood Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.